Recurrent hypoglycemia (RH), the most common side-effect of intensive insulin therapy for diabetes, is well established to diminish counterregulatory responses to further hypoglycemia. However, despite significant patient concern, the impact of RH on cognitive and neural function remains controversial. Here we review both the data from human studies and recent animal studies regarding the impact of RH on cognitive, metabolic, and neural processes. Overall, RH appears to causes brain adaptations which may enhance cognitive performance and fuel supply when euglycemic but which pose significant threats during future hypoglycemic episodes. Our brain runs on glucose: in contrast to cells elsewhere, which will generally take their fuel where they can find it, neurons and glia both rely on a constant supply of glucose from blood for their metabolic support (with some of that glucose being metabolised by astrocytes into lactate which is then exported for subsequent use by neurons). Unsurprisingly, acute interruption of this supply by systemic hypoglycemia produces marked cognitive impairment and leads eventually to coma and death. The consequences of acute hypoglycemia, including effects on cognitive and neural functions, are relatively wellunderstood. In addition and unsurprisingly, repeated severe hypoglycemia causes both significant neuronal death and cognitive impairment [1,2]. However, in recent years the impact on the brain and on cognitive functions of repeated, moderate interruptions of glucose supply, which cause little or no loss of neurons in hippocampus or cortex [3,4], has become of increasing interest. This interest is primarily the result of increased hypoglycemic incidence as a side-effect of advances in therapy for diabetes, but might also be of wider interest because of a potential relationship with the emerging practice of caloric restriction as an aid to long-term physical and mental health. The present review will examine data from both animal and human studies at a variety of levels of analysis. The primary conclusion drawn will be that the long-term consequences of moderate repeated hypoglycemia can be significant, but in general appear to be potentially beneficial at most times. There is, however, significant acerbation of the impact of further episodes of hypoglycemia on cognitive function, so that this risk should be recognised and borne in mind by those receiving or initiating protocols likely to produce such hypoglycemia.The most common cause of hypoglycemia in modern Western society is the use of exogenous insulin as a therapeutic agent for treatment of diabetes. Hypoglycemia has Mailing address: SS369,